AAAAAA

   
Results: 1-8 |
Results: 8
VERTICAL TRANSMISSION OF CYTOMEGALOVIRUS, MOST PROBABLY BY BREAST-MILK, TO AN INFANT WITH WISKOTT-ALDRICH-SYNDROME WITH FATAL OUTCOME
Authors: RICHTER D HAMPL W POHLANDT F
Citation: D. Richter et al., VERTICAL TRANSMISSION OF CYTOMEGALOVIRUS, MOST PROBABLY BY BREAST-MILK, TO AN INFANT WITH WISKOTT-ALDRICH-SYNDROME WITH FATAL OUTCOME, European journal of pediatrics, 156(11), 1997, pp. 854-855
PHOSPHORYLATION OF ACYCLOVIR, GANCICLOVIR, PENCICLOVIR AND S2242 BY THE CYTOMEGALOVIRUS UL97 PROTEIN - A QUANTITATIVE-ANALYSIS USING RECOMBINANT VACCINIA VIRUSES
Authors: ZIMMERMANN A MICHEL D PAVIC I HAMPL W LUSKE A NEYTS J DECLERCQ E MERTENS T
Citation: A. Zimmermann et al., PHOSPHORYLATION OF ACYCLOVIR, GANCICLOVIR, PENCICLOVIR AND S2242 BY THE CYTOMEGALOVIRUS UL97 PROTEIN - A QUANTITATIVE-ANALYSIS USING RECOMBINANT VACCINIA VIRUSES, Antiviral research, 36(1), 1997, pp. 35-42
FLOW CYTOMETRIC ANALYSIS OF HERPES-SIMPLEX VIRUS TYPE-1 SUSCEPTIBILITY TO ACYCLOVIR, GANCICLOVIR, AND FOSCARNET
Authors: PAVIC I HARTMANN A ZIMMERMANN A MICHEL D HAMPL W SCHLEYER I MERTENS T
Citation: I. Pavic et al., FLOW CYTOMETRIC ANALYSIS OF HERPES-SIMPLEX VIRUS TYPE-1 SUSCEPTIBILITY TO ACYCLOVIR, GANCICLOVIR, AND FOSCARNET, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2686-2692
REACTIVATED FULMINANT-HEPATITIS-B VIRUS-REPLICATION AFTER BONE-MARROWTRANSPLANTATION - CLINICAL COURSE AND POSSIBLE TREATMENT WITH GANCICLOVIR
Authors: MERTENS T KOCK J HAMPL W SCHLICHT HJ TILLMANN HL OLDHAFER KJ MANNS MP ARNOLD R
Citation: T. Mertens et al., REACTIVATED FULMINANT-HEPATITIS-B VIRUS-REPLICATION AFTER BONE-MARROWTRANSPLANTATION - CLINICAL COURSE AND POSSIBLE TREATMENT WITH GANCICLOVIR, Journal of hepatology, 25(6), 1996, pp. 968-971
HSV TYPE-1 GENOME VARIANTS FROM PERSISTENTLY PRODUCTIVE INFECTIONS INRAJI AND BJAB CELL-LINES
Authors: KLAUCK SM HAMPL W KLEINSCHMIDT AK
Citation: Sm. Klauck et al., HSV TYPE-1 GENOME VARIANTS FROM PERSISTENTLY PRODUCTIVE INFECTIONS INRAJI AND BJAB CELL-LINES, Archives of virology, 140(7), 1995, pp. 1195-1213
IN-VIVO EX-VIVO T-CELL DEPLETION FOR GVHD PROPHYLAXIS INFLUENCES ONSET AND COURSE OF ACTIVE CYTOMEGALOVIRUS-INFECTION AND DISEASE AFTER BMT
Authors: HERTENSTEIN B HAMPL W BUNJES D WIESNETH M DUNCKER C KOSZINOWSKI U HEIMPEL H ARNOLD R MERTENS T
Citation: B. Hertenstein et al., IN-VIVO EX-VIVO T-CELL DEPLETION FOR GVHD PROPHYLAXIS INFLUENCES ONSET AND COURSE OF ACTIVE CYTOMEGALOVIRUS-INFECTION AND DISEASE AFTER BMT, Bone marrow transplantation, 15(3), 1995, pp. 387-393
INTESTINAL CYTOMEGALOVIRUS DISEASE IN IMMUNOCOMPROMISED PATIENTS MAY BE RULED OUT BY SEARCH FOR CYTOMEGALOVIRUS DNA IN STOOL SAMPLES
Authors: MICHEL D MARRE E HAMPL W ROCZKOS J MULLER S HERTENSTEIN B KERN P HEYMER B SALZBERGER B ARASTEH K MERTENS T
Citation: D. Michel et al., INTESTINAL CYTOMEGALOVIRUS DISEASE IN IMMUNOCOMPROMISED PATIENTS MAY BE RULED OUT BY SEARCH FOR CYTOMEGALOVIRUS DNA IN STOOL SAMPLES, Journal of clinical microbiology, 33(11), 1995, pp. 3064-3067
HUMAN HERPESVIRUS-6 DNA IN EXANTHEMATOUS SKIN IN BMT PATIENT
Authors: MICHEL D MULLER S WORZ S MICHEL M HAMPL W METZGER C FRIEDRICH W MERTENS T
Citation: D. Michel et al., HUMAN HERPESVIRUS-6 DNA IN EXANTHEMATOUS SKIN IN BMT PATIENT, Lancet, 344(8923), 1994, pp. 686-686
Risultati: 1-8 |